Literature DB >> 9880175

The suppression of heterotopic ossifications: radiation versus NSAID therapy--a prospective study.

S Sell1, R Willms, R Jany, S Esenwein, C Gaissmaier, F Martini, G Bruhn, F Burkhardsmaier, M Bamberg, W Küsswetter.   

Abstract

This prospective, randomized study compares the effect of postoperative irradiation and nonsteroidal anti-inflammatory drug (NSAID) therapy on the prevention of heterotopic ossifications after the implantation of a total hip endoprosthesis. A total of 154 operations were performed; one group of patients underwent radiation treatment of 3 x 3.3 Gy, and the other group took 3 x 50 mg of diclofenac per day over a period of 3 weeks. Average age, sex, preoperative diagnosis, and risk factors were similar in both groups. Postoperative radiation began on average 2.9 days after operation, and the radiation therapy was finished on average within 3.8 days. NSAID prophylaxis was begun on the first postoperative day. Heterotopic ossifications occurred in two of the patients who had undergone postoperative prophylaxis by radiation. In both cases, the ossification was Brooker I, and there was no functional impairment. There were no ossifications of Brooker II-IV in this group. One patient had a Staphylococcus epidermidis infection, and fistula revision had to be carried out; the prosthesis could be left in place. In the group treated with NSAID, 16 heterotopic ossifications stage Brooker I and 2 stage Brooker II could be detected. Eleven patients stopped the treatment because of gastrointestinal problems. Both postoperative radiation and NSAID therapy have proved to be effective prophylactic methods. In direct comparison, radiation prophylaxis by 3 x 3.3 Gy proved to be slightly more successful than NSAID prophylaxis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9880175     DOI: 10.1016/s0883-5403(98)90189-9

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  19 in total

Review 1.  Prevention of heterotopic ossification after total hip replacement with NSAIDs.

Authors:  Roel Fijn; Rinco Th Koorevaar; Jacobus R Brouwers
Journal:  Pharm World Sci       Date:  2003-08

2.  Does a plastic drape reduce incidence of heterotopic ossification after hip resurfacing?

Authors:  John S Shields; Ali Mofidi; William G Ward; Riyaz H Jinnah
Journal:  Clin Orthop Relat Res       Date:  2011-06       Impact factor: 4.176

3.  Extra-articular hip impingement due to heterotopic ossification formation at the anterior inferior iliac spine following previous pelvic external fixation.

Authors:  Scott M Sandilands; Brandon L Raudenbush; Dominic S Carreira; Brian J Cross
Journal:  BMJ Case Rep       Date:  2016-09-16

Review 4.  Prophylaxis of heterotopic ossification of the hip: systematic review and meta-analysis.

Authors:  Patrick Vavken; Lorenzo Castellani; Thomas P Sculco
Journal:  Clin Orthop Relat Res       Date:  2009-06-11       Impact factor: 4.176

5.  Heterotopic Ossification of the Finger Following Closed Blunt Trauma.

Authors:  Esther Wan Xian Tan; Sechachalam Sreedharan
Journal:  J Hand Microsurg       Date:  2014-08-28

Review 6.  Retinoid roles and action in skeletal development and growth provide the rationale for an ongoing heterotopic ossification prevention trial.

Authors:  Maurizio Pacifici
Journal:  Bone       Date:  2017-08-19       Impact factor: 4.398

7.  Safety and efficacy of routine postoperative ibuprofen for pain and disability related to ectopic bone formation after hip replacement surgery (HIPAID): randomised controlled trial.

Authors:  Marlene Fransen; Craig Anderson; Jan Douglas; Stephen MacMahon; Bruce Neal; Robyn Norton; Mark Woodward; Ian D Cameron; Ross Crawford; Sing Kai Lo; Garnet Tregonning; Margaret Windolf
Journal:  BMJ       Date:  2006-08-02

8.  Acute revision hip arthroplasty: a previously unrecognized risk factor for heterotopic ossification.

Authors:  Abdulaziz Aljurayyan; Dylan Tanzer; Michael Tanzer
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-01-02

9.  Effectiveness and mode of action of a combination therapy for heterotopic ossification with a retinoid agonist and an anti-inflammatory agent.

Authors:  Sayantani Sinha; Kenta Uchibe; Yu Usami; Maurizio Pacifici; Masahiro Iwamoto
Journal:  Bone       Date:  2016-02-15       Impact factor: 4.398

Review 10.  Acquired and congenital forms of heterotopic ossification: new pathogenic insights and therapeutic opportunities.

Authors:  Maurizio Pacifici
Journal:  Curr Opin Pharmacol       Date:  2018-03-31       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.